B-Vitamins and the Risk of total Mortality and Cardiovascular Disease in End-Stage Renal Disease.

Completed

• Conditions: Total mortality and cardiovascular disease in patients with end-stage renal disease; Cardiovascular - Coronary heart disease; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12609000911291
• Lead Sponsor: Prof. Dr. C. Luley

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-01-16
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 700

Inclusion Criteria

age 20-80 years
- end-stage renal disease
- treatment with hemodialysis

Exclusion Criteria

- addiction to drugs or alcohol
- legal incapacity
- missing consent
- acute cardiovascular events (6 weeks before enrollment)
- pregnancy and lactation

Study & Design

• Study Type: Interventional
• Study Design: Not specified